Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review
L Cho, M Davis, I Elgendy, K Epps, KJ Lindley… - Journal of the American …, 2020 - jacc.org
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for
women in the United States and worldwide. There has been no American College of …
women in the United States and worldwide. There has been no American College of …
The rise and fall of aspirin in the primary prevention of cardiovascular disease
I Raber, CP McCarthy, M Vaduganathan, DL Bhatt… - The Lancet, 2019 - thelancet.com
Aspirin is one of the most frequently used drugs worldwide and is generally considered
effective for the secondary prevention of cardiovascular disease. By contrast, the role of …
effective for the secondary prevention of cardiovascular disease. By contrast, the role of …
Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement
KW Davidson, MJ Barry, CM Mangione, M Cabana… - Jama, 2022 - jamanetwork.com
Importance Cardiovascular disease (CVD) is the leading cause of mortality in the US,
accounting for more than 1 in 4 deaths. Each year, an estimated 605 000 people in the US …
accounting for more than 1 in 4 deaths. Each year, an estimated 605 000 people in the US …
Aspirin use to prevent cardiovascular disease and colorectal cancer: updated evidence report and systematic review for the US preventive services task force
JM Guirguis-Blake, CV Evans, LA Perdue, SI Bean… - Jama, 2022 - jamanetwork.com
Importance Low-dose aspirin is used for primary cardiovascular disease prevention and
may have benefits for colorectal cancer prevention. Objective To review the benefits and …
may have benefits for colorectal cancer prevention. Objective To review the benefits and …
Value of coronary artery calcium scanning in association with the net benefit of aspirin in primary prevention of atherosclerotic cardiovascular disease
E Ajufo, CR Ayers, R Vigen, PH Joshi… - JAMA …, 2021 - jamanetwork.com
Importance Higher coronary artery calcium (CAC) identifies individuals at increased
atherosclerotic cardiovascular disease (ASCVD) risk. Whether it can also identify individuals …
atherosclerotic cardiovascular disease (ASCVD) risk. Whether it can also identify individuals …
Revisiting the role of aspirin for the primary prevention of cardiovascular disease
G Marquis-Gravel, MT Roe, RA Harrington, D Munoz… - Circulation, 2019 - Am Heart Assoc
Aspirin is the cornerstone of the antithrombotic management of patients with established
atherosclerotic cardiovascular disease, but major guidelines provide conflicting …
atherosclerotic cardiovascular disease, but major guidelines provide conflicting …
Personalized prediction of cardiovascular benefits and bleeding harms from aspirin for primary prevention: a benefit–harm analysis
V Selak, R Jackson, K Poppe, B Wu… - Annals of Internal …, 2019 - acpjournals.org
Background: Whether the benefits of aspirin for the primary prevention of cardiovascular
disease (CVD) outweigh its bleeding harms in some patients is unclear. Objective: To …
disease (CVD) outweigh its bleeding harms in some patients is unclear. Objective: To …
Aspirin use to prevent cardiovascular disease and colorectal cancer: updated modeling study for the US Preventive Services Task Force
SP Dehmer, LR O'Keefe, CV Evans, JM Guirguis-Blake… - JAMA, 2022 - jamanetwork.com
Importance The US Preventive Services Task Force (USPSTF) is updating its 2016
recommendation on the use of aspirin for the primary prevention of cardiovascular disease …
recommendation on the use of aspirin for the primary prevention of cardiovascular disease …
Aspirin in primary prevention: what changed? A critical appraisal of current evidence
O Dasa, CJ Pepine, TA Pearson - The American journal of cardiology, 2021 - Elsevier
Aspirin has been the mainstay of both secondary and primary prevention of cardiovascular
disease for half a century. In 2018, 3 trials showed a modest reduction in cardiovascular …
disease for half a century. In 2018, 3 trials showed a modest reduction in cardiovascular …
[HTML][HTML] 阿司匹林用于心血管病一级预防的不同策略比较： 一项马尔可夫模型研究
张明露， 刘秋萍， 巩超， 王佳敏， 周恬静… - Journal of Peking …, 2023 - ncbi.nlm.nih.gov
阿司匹林用于心血管病一级预防的不同策略比较：一项马尔可夫模型研究- PMC Back to Top
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …